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COMMENTARY
Inflammation biomarkers and delirium in critically
ill patients: new insights?
Shokoufeh Cheheili Sobbi and Mark van den Boogaard*
See related research by Ritter et al., http://ccforum.com/content/18/3/R106/
Abstract
The pathophysiological mechanism of the serious and
frequently occurring disorder delirium is poorly
understood. Inflammation and sepsis are known risk
factors for ICU delirium and therefore these patients
are highly susceptible to delirium. Several studies have
been performed to determine which cytokines are
most associated with delirium but the results are
inconclusive. Also, new biomarkers associated with
brain dysfunction and cognitive impairment are still
recognized and need to be studied to determine their
relation with delirium. In this commentary we address
some limitations concerning an interesting new study
that warrants directions for future studies.
We read with interest the study by Ritter and colleagues
in which the relationship between inflammatory bio-
markers and the development of delirium was investigated
[1]. While delirium in critically ill patients is recognized as
a major problem associated with deleterious outcome, the
pathophysiology is still poorly understood. Apart from a
role in further unraveling pathophysiological pathways in
delirium, biomarkers could possibly also be used as
diagnostic or prognostic disease markers. This task might
prove to be difficult, as delirium is a multifactorial dis-
order and thus several pathways are probably involved in
its development [2]. Studying the underlying mechanism
of delirium in a relatively homogeneous study population,
as Ritter and colleagues did in 78 inflamed patients [1],
could minimize the interaction between different path-
ways. Patients with systemic inflammation or sepsis are
highly vulnerable to developing brain dysfunction and
delirium, also defined as sepsis-associated delirium or
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sepsis-associated encephalopathy [3], and could therefore
serve this purpose.
Ritter and colleagues studied TNFα, soluble TNF
receptor (STNFR)-1, STNFR2, IL-1β, IL-6, IL-10 and
adiponectin in systemic inflamed patients in relation to
delirium [1]. In their prospective cohort study they
found significant associations between STNFR1, STNFR2,
IL-1β and adiponectin concentrations and the develop-
ment of delirium.
We previously found that delirium was associated with
IL-8 (odds ratio, 9.0; 95% confidence interval, 1.8 to
44.0) and IL-10 (odds ratio, 2.6; 95% confidence interval,
1.1 to 5.9) but not with TNFα in inflamed ICU patients
[4]. In contrast, Ritter and colleagues found no associ-
ation between IL-10 and delirium. This discrepancy
might be explained by differences in study design: Ritter
and colleagues collected blood samples within 12 hours
of ICU admission, while in our study blood was drawn
within 24 hours after the onset of delirium regardless of
ICU length of stay. In view of the changes over time in
the concentration of cytokines and the development of
delirium, serial determinations of circulating inflamma-
tory markers and the relationship with the development
of delirium would be of great interest, but this has not
been carried out in ICU patients up to now.
Surprisingly, Ritter and colleagues found no differ-
ences in several patient characteristics such as age,
severity of illness scores, and duration of mechanical
ventilation, but also not in the presence of sepsis,
between delirious and nondelirious ICU patients, while
these characteristics are clearly recognized as risk factors
for delirium [5-7]. A possible explanation for why they
did not find these differences could be the frequency of
delirium assessment. Due to its fluctuating course, delir-
ium can be missed when patients are assessed with the
Confusion Assessment Method for the Intensive Care
Unit only twice a day – especially when it is recognized
that on average 20% of delirium is missed when using
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the Confusion Assessment Method for the Intensive
Care Unit [8]. This fact may also explain the observed
relatively low delirium incidence (39.7%) in these highly
susceptible patients suffering from systemic inflammation.
Another interesting and very relevant point is that
Ritter and colleagues also studied, besides the common
proinflammatory and anti-inflammatory cytokines, the
hormone adiponectin. Adiponectin was recently deter-
mined to interact with the brain [9] and to play a role
in neuroprotection and energy expenditure. Levels of
adiponectin are elevated in critically ill patients [10]
and even higher in delirious ICU patients, as Ritter and
colleagues determined [1]. These authors are the first
to determine an association between adiponectin levels
(adjusted for weight) and delirium.
Although not a primary study aim, Ritter and colleagues
also determined the accuracy of the prediction of delirium
using these biomarkers. Even though IL-β, STNFR1,
STNFR2 and adiponectin individually predict delirium
moderately well (area under the receiver operating
characteristics curve: 0.70 to 0.84), the authors did not
mention the overall area under the receiver operating
characteristics curve of the model using multivariate
regression analysis. Unfortunately the sample size in
their study did not allow inclusion of other relevant risk
factors. In daily clinical practice, therefore, using a delir-
ium prediction model specifically developed for predic-
tion based on clinical risk factors appears better [11].
Despite these shortcomings, their study was well designed
and their findings are very relevant to further progress
this field.
Currently, the role of biomarkers as Ritter and
colleagues determined is, although relevant, still limited
for daily clinical practice. Serial measurements of inflam-
matory markers in ICU patients and further research into
the role of adiponectin in the development of delirium
warrant further investigation in future studies.
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